Soleno Therapeutics (SLNO) Amortizatization of Intangibles (2024 - 2026)

Soleno Therapeutics (SLNO) has 3 years of Amortizatization of Intangibles data on file, last reported at $221000.0 in Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 77.45% year-over-year to $221000.0 in Q1 2026; TTM through Mar 2026 was $2.8 million, a 48.94% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 28.15% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $221000.0, down from $1.2 million in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for SLNO reached as high as $1.9 million in Q3 2024 and fell as low as $221000.0 in Q1 2026.
• Historically, Amortizatization of Intangibles has averaged $959222.2 across 3 years, with a median of $980000.0 in 2025.
• On a YoY basis, Amortizatization of Intangibles climbed as much as 107.19% in 2025 and fell as far as 80.57% in 2025.
• Year by year, Amortizatization of Intangibles stood at $1.4 million in 2024, then retreated by 14.86% to $1.2 million in 2025, then tumbled by 81.46% to $221000.0 in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $221000.0 in Q1 2026, $1.2 million in Q4 2025, and $371000.0 in Q3 2025.